Investigating arm swing characteristics in COPD patients
Kronik Obstrüktif Akciğer Hastalığında Yürüyüş Sırasında Yürüyüşün Zaman Mesafe Karakteristikleri ve Kol Salınımlarının İncelenmesi
This study looks at how arm movements in people with COPD are different from those in healthy individuals to see if these differences relate to their balance and disease severity.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 40 (estimated) |
| Ages | 40 Years to 65 Years |
| Sex | All |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara) |
| Trial ID | NCT05746702 on ClinicalTrials.gov |
What this trial studies
This observational study aims to analyze how arm swings differ in patients with Chronic Obstructive Pulmonary Disease (COPD) compared to healthy individuals. It will assess the correlation between arm swing characteristics, balance parameters, and the severity of the disease in participants. The study will include 20 patients with COPD at GOLD stages 1-3 and 20 healthy controls aged 40 to 65. Various tests, including the Berg Balance Scale and the 6 Minute Walk Test, will be utilized to evaluate the participants' balance and posture.
Who should consider this trial
Good fit: Ideal candidates are clinically stable COPD patients aged 40-65 who can walk independently for 6 minutes.
Not a fit: Patients using walking assistive devices or those with significant comorbidities affecting gait and balance may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the relationship between arm swing and balance in COPD patients, potentially leading to improved rehabilitation strategies.
How similar studies have performed: While similar studies have explored gait and balance in COPD, this specific focus on arm swing characteristics is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Who has been clinically stable for the last 4 weeks, * who will be able to walk independently for 6 minutes, * According to the Classification of Airflow Limitation in COPD (GOLD) system, the Stage is 1-2-3, * who declares that he has not taken part in any other research Exclusion Criteria: * walking assistive devices, * receiving chronic oxygen therapy, * with central and peripheral vestibular disease, * with orthopedic, neuromuscular, neurological and cardiac diseases that may affect gait and balance, * with a history of lung cancer, sarcoidosis, tuberculosis and/or lung surgery, * who has communication problems, * with mental and cognitive problems
Where this trial is running
Ankara
- Aynur Demirel — Ankara, Turkey (Recruiting)
Study contacts
- Principal investigator: Aynur Demirel, PhD — Hacettepe University
- Study coordinator: Aynur Demirel, PhD
- Email: aynur.demirel@hacettepe.edu.tr
- Phone: +90 3123051576
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.